Company: DXPE
Filing Date: 2025-04-30
Form Type: ARS
Source: 0001020710-25-000081
Chunk: 92

Company: DXP ENTERPRISES INC
Filing Date: 2025-04-30
Form: ARS
Chunk 92
---
 in RSAs for the twelve months ended December 31, 2023 are as follows: Number of Shares Weighted Average Grant Price Non-vested at December 31, 2022 157,767 $ 28.64 Granted 215,554 $ 27.36 Forfeited — $ — Vested (68,884) $ 29.23 Non-vested at December 31, 2023 304,437 $ 27.60 Changes in RSAs for the twelve months ended December 31, 2022 are as follows: Number of Shares Weighted Average Grant Price Non-vested at December 31, 2021 112,044 $ 31.72 Granted 113,077 $ 27.48 Forfeited (8,785) $ 31.96 Vested (58,569) $ 31.79 Non-vested at December 31, 2022 157,767 $ 28.64 Table of Contents 69

Compensation expense, associated with RSAs, recognized in the years ended December 31, 2024, December 31, 2023 and December 31, 2022 was $4.7 million, $3.1 million and $1.9 million, respectively. Related income tax benefits recognized in earnings in the years ended December 31, 2024, December 31, 2023 and December 31, 2022 were approximately $0.8 million, $0.8 million and $0.5 million, respectively. The aggregate grant-date fair value of vested shares for the years ended December 31, 2024, December 31, 2023 and December 31, 2022 was $3.4 million, $2.0 million and $1.9 million, respectively. Unrecognized compensation expense under the 2016 Plan at December 31, 2024, December 31, 2023 and December 31, 2022 was $7.7 million, $5.9 million and $3.1 million, respectively. As of December 31, 2024, the weighted average period over which the unrecognized compensation expense is expected to be recognized is 1.5 years. NOTE 12 - EARNINGS PER SHARE DATA Basic earnings per share is computed based on weighted average shares outstanding and excludes dilutive securities. Diluted earnings per share is computed including the impacts of all potentially dilutive securities. The